Molecular Immunology Center
- Categories:External Cooperation
- Author:
- Origin:
- Time of issue:2021-09-03
- Views:
(Summary description)Molecular Immunology Center(CIM) is an internationally renowned comprehensive scientific research institution and one of the five largest biotechnology research institutions in Cuba. It is mainly engaged in basic research, development and production of mammalian cell culture products that meet cGMP standards. It has leading mature experience in the development of tumor therapeutic vaccines and antibody drugs, and has discovered and confirmed a variety of new drug targets, providing new strategies for tumor treatment. CIM is a strategic partner of BIotech Pharma, through international scientific and technological cooperation, to import Cuba's advanced basic research, clinical research and industrialization technology into the country. After digestion, absorption, integration, innovation, and training and guidance with an external expert team, it has consolidated the foundation of cooperation between Biotech and Cuba in basic research such as molecular immunology, joint development of antibody drugs and other applied research and industrialization, and has achieved substantial breakthrough research results. In view of the effectiveness of the cooperation between the two parties, under the co-chairmanship of the Ministry of Science and Technology of China and the Ministry of Science, Technology and Environment of Cuba, the "Medieval Molecular Immunology Center" was established in Biotech.
Molecular Immunology Center
(Summary description)Molecular Immunology Center(CIM) is an internationally renowned comprehensive scientific research institution and one of the five largest biotechnology research institutions in Cuba. It is mainly engaged in basic research, development and production of mammalian cell culture products that meet cGMP standards. It has leading mature experience in the development of tumor therapeutic vaccines and antibody drugs, and has discovered and confirmed a variety of new drug targets, providing new strategies for tumor treatment. CIM is a strategic partner of BIotech Pharma, through international scientific and technological cooperation, to import Cuba's advanced basic research, clinical research and industrialization technology into the country. After digestion, absorption, integration, innovation, and training and guidance with an external expert team, it has consolidated the foundation of cooperation between Biotech and Cuba in basic research such as molecular immunology, joint development of antibody drugs and other applied research and industrialization, and has achieved substantial breakthrough research results.
In view of the effectiveness of the cooperation between the two parties, under the co-chairmanship of the Ministry of Science and Technology of China and the Ministry of Science, Technology and Environment of Cuba, the "Medieval Molecular Immunology Center" was established in Biotech.
- Categories:External Cooperation
- Author:
- Origin:
- Time of issue:2021-09-03 09:59
- Views:
Molecular Immunology Center (CIM) is an internationally renowned scientific research institution, and is one the five largest biotechnology research institutions in Cuba. CIM is mainly engaged in the basic research, development and production of products cultured by mammalian cell. CIM has rich experiences in the development of antibodies and therapeutic vaccines for tumor treatment, and has discovered and validate various new targets, providing alternative strategies for cancer treatment.
BPL and CIM work together to continuously optimize technologies in R&D and production, and jointly cultivate talents with the assistance of Cuban experts from CIM. More than 20-year cooperation has laid solid foundation in the basic research, antibody R&D as well as large-scale production, and yielded substantial and breakthrough results. In view of the effectiveness of the cooperation between BPL and CIM, the "China-Cuba Molecular Immunology Center" was established in BPL, which was co-chaired by the Ministry of Science and Technology of China and the Ministry of Science, Technology and Environment of Cuba.
Biotech pharmaceutical co., Ltd
Biotech pharmaceutical co., Ltd 京ICP备05019954号 互联网药品信息编号:(京)非经营性2016-0046 www.300.cn